Flora Growth (NASDAQ: FLGC), a leading all-outdoor cultivator and manufacturer of global cannabis products and brands, announced that it has received Good Manufacturing Practices (“GMP”) certification from the Colombian National Food and Drug Surveillance Institute (“INVIMA”) authorizing the manufacture of cosmetics products. Effective immediately, the GMP authorization allows Flora to offer cosmetic products for export to international markets that require goods meet the rigorous GMP standards. The authorization also recognizes the Flora lab for its quality procedures, which are in line with global pharmaceutical companies, and demonstrates the company’s operational excellence and capability of achieving pharmaceutical-grade standards. Those standards are recognized by regulators around the world as representative of high-quality products. According to the announcement, the certification is an essential component of Flora’s global supply chain strategy and distribution plan as the company plans to produce cosmetic products containing cannabinoids at its Colombian facility. The products will be branded for both the company’s Flora Beauty division and for white-label clients. FLGC’s lab currently holds three GMP certifications and produces an impressive portfolio of more than 190 products and 63 over-the-counter products that are registered and licensed with INVIMA. The company is looking to expand its more than distribution channels in Colombia and gain international clients as well. “Attaining this certification is a significant accomplishment for our team as it demonstrates our ability to achieve pharmaceutical-grade standards recognized by regulators throughout the world and producing consistent, safe, high-quality cosmetic products,” said Flora Growth president and CEO Luis Merchan in the press release. “Out of more than 650 cosmetics laboratories throughout Colombia, Flora Lab is only the 13th company to successfully navigate and implement the rigorous quality standards necessary to reach this level of manufacturing excellence. As we look to bring our premium brands and products to markets around the world, this certification represents a key component of our supply chain strategy and distribution plan. We can now pursue distribution agreements for the sale of cannabinoid and noncannabinoid containing cosmetic products in global markets where GMP certification is required for market access.”
To view the full press release, visit https://ibn.fm/yZVL4
About Flora Growth Corp.
Flora Growth is a cannabis company that leverages natural, cost-effective cultivation practices to supply cannabis derivatives to its diverse business divisions of cosmetics, hemp textiles, and food and beverage. As the operator of one of the largest outdoor cultivation facilities, Flora strives to market a higher-quality premium product at below-market prices. By prioritizing natural ingredients and value-chain sustainability across its portfolio, Flora creates premium products that help consumers restore and thrive. For more information about the company, please visit www.FloraGrowth.ca.
NOTE TO INVESTORS: The latest news and updates relating to FLGC are available in the company’s newsroom at https://ibn.fm/FLGC
About MissionIRNewsBreaks
MissionIRNewsBreaks provide a rapid summary of corporate news that catch the attention of MissionIR. MissionIRNewsBreaks are created by our Team of professional journalists that keep a constant eye on the markets, these posts are designed to inform you on the latest happenings of our clients and other publicly traded companies on our radar. From earnings, acquisitions and agreements to conference attendance and clinical study results, our news breaks keep you up-to-date with the day’s top movers. MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.
MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
[email protected]
Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html
